Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Proceedings of the National Academy of Sciences of the United States of America|March 8, 2022
Inhibitors of PARP: Number crunching and structure gazingJohannes Rudolph, Karen Jung, Karolin LugerExpert Opinion on Therapeutic Targets|December 21, 2022
Granzyme B as a therapeutic target: an update in 2022Alexandre Aubert, Michael Lane, Karen Jung, et al.Nature Reviews. Rheumatology|April 30, 2024
Granzyme serine proteases in inflammation and rheumatic diseasesAlexandre Aubert, Karen Jung, Sho Hiroyasu, et al.American Journal of Physiology. Cell Physiology|April 20, 2022
Granzyme B in epithelial barrier dysfunction and related skin diseasesKaren Jung, Megan A Pawluk, Michael Lane, et al.BMC Cancer|June 3, 2014
YB-1 regulates Sox2 to coordinately sustain stemness and tumorigenic properties in a phenotypically distinct subset of breast cancer cellsKaren Jung, Fang Wu, Peng Wang, et al.Physiology (Bethesda, Md.)|July 12, 2022
Noncytotoxic Roles of Granzymes in Health and DiseaseKatlyn C Richardson, Karen Jung, Julian Pardo, et al.Trends in Molecular Medicine|August 24, 2024
Granzyme B in aging and age-related pathologiesKatlyn C Richardson, Karen Jung, Joanne A Matsubara, et al.Cancer Biology & Therapy|June 11, 2015
Elevated ARG1 expression in primary monocytes-derived macrophages as a predictor of radiation-induced acute skin toxicities in early breast cancer patientsKaren Jung, Siham Sabri, John Hanson, et al.Cellular Signalling|December 3, 2013
β-Catenin, a Sox2 binding partner, regulates the DNA binding and transcriptional activity of Sox2 in breast cancer cellsXiaoxia Ye, Fang Wu, Chengsheng Wu, et al.BMC Cancer|July 3, 2013
Sox2 suppresses the invasiveness of breast cancer cells via a mechanism that is dependent on Twist1 and the status of Sox2 transcription activityFang Wu, Xiaoxia Ye, Peng Wang, et al.Pageof 2